{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:32:46Z","timestamp":1784827966695,"version":"3.55.0"},"reference-count":51,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T00:00:00Z","timestamp":1400544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T00:00:00Z","timestamp":1400544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Canadian Institutes of Health Research Operating Grant"},{"name":"NIH\/NIDDK","award":["K01 DK080184"],"award-info":[{"award-number":["K01 DK080184"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurourol. Urodynam."],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1002\/nau.22582","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T17:05:59Z","timestamp":1400605559000},"page":"611-617","source":"Crossref","is-referenced-by-count":26,"title":["Pathophysiology of idiopathic overactive bladder and the success of treatment: A systematic review from ICI-RS 2013"],"prefix":"10.1002","volume":"33","author":[{"given":"Ann T.","family":"Hanna-Mitchell","sequence":"first","affiliation":[{"name":"University Hospitals Case Medical Center and Department of Urology; Urology Institute; Case Western Reserve University School of Medicine; Cleveland Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandavi","family":"Kashyap","sequence":"additional","affiliation":[{"name":"Centre de recherche de l'Institut universitaire de g\u00e9riatrie de Montr\u00e9al; Montreal Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson Ventura","family":"Chan","sequence":"additional","affiliation":[{"name":"McGill University; Montreal Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Eric","family":"Andersson","sequence":"additional","affiliation":[{"name":"Institute for Regenerative Medicine; Wake Forest University School of Medicine; Winston Salem North Carolina"},{"name":"Institute for Clinical Medicine; Aarhus University; Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Tannenbaum","sequence":"additional","affiliation":[{"name":"Centre de recherche de l'Institut universitaire de g\u00e9riatrie de Montr\u00e9al; Montreal Canada"},{"name":"Faculty of Medicine; Universit\u00e9 de Montr\u00e9al; Montreal Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,5,20]]},"reference":[{"key":"10.1002\/nau.22582-BIB0001|nau22582-cit-0001","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.bjp.0706780","article-title":"Muscarinic receptors: Their distribution and function in body systems, and the implications for treating overactive bladder","volume":"148","author":"Abrams","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1002\/nau.22582-BIB0002|nau22582-cit-0002","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.eururo.2009.07.044","article-title":"A refocus on the bladder as the originator of storage lower urinary tract symptoms: A systematic review of the latest literature","volume":"56","author":"Roosen","year":"2009","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22582-BIB0003|nau22582-cit-0003","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00192-012-1682-6","article-title":"Pathophysiology of overactive bladder","volume":"23","author":"Banakhar","year":"2012","journal-title":"Int Urogynecol J"},{"key":"10.1002\/nau.22582-BIB0004|nau22582-cit-0004","doi-asserted-by":"crossref","first-page":"967e1","DOI":"10.1016\/j.urology.2011.06.041","article-title":"The effects of acute and chronic psychological stress on bladder function in a rodent model","volume":"78","author":"Smith","year":"2011","journal-title":"Urology"},{"key":"10.1002\/nau.22582-BIB0005|nau22582-cit-0005","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.juro.2010.04.083","article-title":"Gating of sensory information differs in patients with interstitial cystitis\/painful bladder syndrome","volume":"184","author":"Kilpatrick","year":"2010","journal-title":"J Urol"},{"key":"10.1002\/nau.22582-BIB0006|nau22582-cit-0006","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0090-4295(00)00988-2","article-title":"Stress and symptoms in patients with interstitial cystitis: A life stress model","volume":"57","author":"Rothrock","year":"2001","journal-title":"Urology"},{"key":"10.1002\/nau.22582-BIB0007|nau22582-cit-0007","doi-asserted-by":"crossref","first-page":"F688","DOI":"10.1152\/ajprenal.00133.2008","article-title":"Modulation of bladder myofibroblast activity: Implications for bladder function","volume":"295","author":"Sui","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1002\/nau.22582-BIB0008|nau22582-cit-0008","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/nau.20739","article-title":"Interstitial cells in the urinary bladder-localization and function","volume":"29","author":"McCloskey","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22582-BIB0009|nau22582-cit-0009","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.autneu.2013.03.010","article-title":"Highlights in basic autonomic neuroscience: Contribution of the urothelium to sensory mechanisms in the urinary bladder","volume":"177","author":"de Groat","year":"2013","journal-title":"Auton Neurosci"},{"key":"10.1002\/nau.22582-BIB0010|nau22582-cit-0010","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/nn902","article-title":"Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1","volume":"5","author":"Birder","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1002\/nau.22582-BIB0011|nau22582-cit-0011","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1113\/jphysiol.2007.139147","article-title":"Bladder afferent sensitivity in wild-type and TRPV1 knockout mice","volume":"583","author":"Daly","year":"2007","journal-title":"J Physiol"},{"key":"10.1002\/nau.22582-BIB0012|nau22582-cit-0012","doi-asserted-by":"crossref","first-page":"F1018","DOI":"10.1152\/ajprenal.00183.2007","article-title":"Role of gap junctions in spontaneous activity of the rat bladder","volume":"293","author":"Ikeda","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1002\/nau.22582-BIB0013|nau22582-cit-0013","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1464-410X.2005.05988.x","article-title":"The functional effects of a c-kit tyrosine inhibitor on guinea-pig and human detrusor","volume":"97","author":"Biers","year":"2006","journal-title":"BJU Int"},{"key":"10.1002\/nau.22582-BIB0014|nau22582-cit-0014","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.eururo.2008.11.009","article-title":"Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment","volume":"55","author":"Roosen","year":"2009","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22582-BIB0015|nau22582-cit-0015","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1152\/physrev.00030.2012","article-title":"Urothelial signaling","volume":"93","author":"Birder","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1002\/nau.22582-BIB0016|nau22582-cit-0016","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0090-4295(97)00583-9","article-title":"Diagnosis and significance of idiopathic overactive bladder","volume":"50","author":"Artibani","year":"1997","journal-title":"Urology"},{"key":"10.1002\/nau.22582-BIB0017|nau22582-cit-0017","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22582-BIB0018|nau22582-cit-0018","doi-asserted-by":"crossref","first-page":"R701","DOI":"10.1152\/ajpregu.00009.2003","article-title":"Hypertrophy changes the muscarinic receptor subtype mediating bladder contraction from M3 toward M2","volume":"285","author":"Braverman","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1002\/nau.22582-BIB0019|nau22582-cit-0019","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/nau.20502","article-title":"Altered distribution of interstitial cells in the guinea pig bladder following bladder outlet obstruction","volume":"27","author":"Kubota","year":"2008","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22582-BIB0020|nau22582-cit-0020","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/nau.22214","article-title":"How should bladder sensation be measured? ICI-RS 2011","volume":"31","author":"De Wachter","year":"2012","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22582-BIB0021|nau22582-cit-0021","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/nau.22357","article-title":"Urge urinary incontinence and the brain factor","volume":"32","author":"Morris","year":"2013","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22582-BIB0022|nau22582-cit-0022","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1001\/jama.288.18.2293","article-title":"Behavioral training with and without biofeedback in the treatment of urge incontinence in older women: A randomized controlled trial","volume":"288","author":"Burgio","year":"2002","journal-title":"JAMA"},{"key":"10.1002\/nau.22582-BIB0023|nau22582-cit-0023","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1096\/fj.00-0850rev","article-title":"Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors","volume":"15","author":"Slominski","year":"2001","journal-title":"FASEB J"},{"key":"10.1002\/nau.22582-BIB0024|nau22582-cit-0024","first-page":"33","article-title":"Corticotropin releasing factor signaling in colon and ileum: Regulation by stress and pathophysiological implications","volume":"60","author":"Larauche","year":"2009","journal-title":"J Physiol Pharmacol"},{"key":"10.1002\/nau.22582-BIB0025|nau22582-cit-0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.autneu.2008.05.007","article-title":"Postnatal expression of corticotropin releasing factor (CRF) in rat urinary bladder","volume":"141","author":"LaBerge","year":"2008","journal-title":"Auton Neurosci"},{"key":"10.1002\/nau.22582-BIB0026|nau22582-cit-0026","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.urology.2007.06.1117","article-title":"Relationship of lifestyle and clinical factors to lower urinary tract symptoms: Results from Boston Area Community Health survey","volume":"70","author":"Litman","year":"2007","journal-title":"Urology"},{"key":"10.1002\/nau.22582-BIB0027|nau22582-cit-0027","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1464-410X.2009.08371.x","article-title":"The burden of lower urinary tract symptoms: Evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS","volume":"103","author":"Coyne","year":"2009","journal-title":"BJU Int"},{"key":"10.1002\/nau.22582-BIB0028|nau22582-cit-0028","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/nau.20916","article-title":"Potential insights into lower urinary function derived from CNS imaging","volume":"29","author":"Drake","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22582-BIB0029|nau22582-cit-0029","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF01962573","article-title":"Oxybutynin and bladder training in the management of female urinary urge incontinence: A randomized study","volume":"6","author":"Colombo","year":"1995","journal-title":"Int Urogynecol J"},{"key":"10.1002\/nau.22582-BIB0030|nau22582-cit-0030","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1464-410X.2009.09037.x","article-title":"Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity","volume":"105","author":"Nitti","year":"2010","journal-title":"BJU Int"},{"key":"10.1002\/nau.22582-BIB0031|nau22582-cit-0031","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/01443610120059941","article-title":"Vaginal oestradiol for the treatment of lower urinary tract symptoms in postmenopausal women-a double-blind placebo-controlled study","volume":"21","author":"Cardozo","year":"2001","journal-title":"J Obstet Gynaecol"},{"key":"10.1002\/nau.22582-BIB0032|nau22582-cit-0032","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1464-410X.2009.08361.x","article-title":"Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study","volume":"103","author":"Malone-Lee","year":"2009","journal-title":"BJU Int"},{"key":"10.1002\/nau.22582-BIB0033|nau22582-cit-0033","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1464-410x.1998.00717.x","article-title":"Tolterodine, a new antimuscarinic agent: As effective but better tolerated than oxybutynin in patients with an overactive bladder","volume":"81","author":"Abrams","year":"1998","journal-title":"Br J Urol"},{"key":"10.1002\/nau.22582-BIB0034|nau22582-cit-0034","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/0011-393X(95)85118-6","article-title":"The effects of an estradiol transdermal therapeutic system, alone and in combination with naproxen, on urge incontinence in elderly women: A pilot study","volume":"56","author":"Blom","year":"1995","journal-title":"Curr Ther Res"},{"key":"10.1002\/nau.22582-BIB0035|nau22582-cit-0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.urology.2012.03.035","article-title":"Phase IIb, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to determine effects of elocalcitol in women with overactive bladder and idiopathic detrusor overactivity","volume":"80","author":"Digesu","year":"2012","journal-title":"Urology"},{"key":"10.1002\/nau.22582-BIB0036|nau22582-cit-0036","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/nau.20300","article-title":"Intravesical resiniferatoxin for the treatment of women with idiopathic detrusor overactivity and urgency incontinence: A single dose, 4 weeks, double-blind, randomized, placebo controlled trial","volume":"26","author":"Rios","year":"2007","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22582-BIB0037|nau22582-cit-0037","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s00240-004-0402-1","article-title":"The effect of intravesical sodium nitroprusside on idiopathic detrusor overactivity","volume":"32","author":"Tarhan","year":"2004","journal-title":"Urol Res"},{"key":"10.1002\/nau.22582-BIB0038|nau22582-cit-0038","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.eururo.2011.12.056","article-title":"Botulinum toxin a versus placebo for refractory detrusor overactivity in women: A randomised blinded placebo-controlled trial of 240 women (the RELAX study)","volume":"62","author":"Tincello","year":"2012","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22582-BIB0039|nau22582-cit-0039","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2165\/00044011-200121080-00005","article-title":"Randomised, Double-Blind, Placebo-Controlled Study on the Efficacy and Tolerance of Trospium Chloride in Patients with Motor Urge Incontinence","volume":"21","author":"Ulsh\u00f6fer","year":"2001","journal-title":"Clin Drug Investig"},{"key":"10.1002\/nau.22582-BIB0040|nau22582-cit-0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.eururo.2009.04.045","article-title":"Cizolirtine citrate is safe and effective for treating urinary incontinence secondary to overactive bladder: A phase 2 proof-of-concept study","volume":"57","author":"Zat'ura","year":"2010","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22582-BIB0041|nau22582-cit-0041","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.eururo.2005.04.023","article-title":"Propiverine versus tolterodine: Efficacy and tolerability in patients with overactive bladder","volume":"48","author":"Junemann","year":"2005","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22582-BIB0042|nau22582-cit-0042","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1464-410X.2002.02905.x","article-title":"A randomized controlled trial of tolterodine and oxybutynin on tolerability and clinical efficacy for treating Chinese women with an overactive bladder","volume":"90","author":"Leung","year":"2002","journal-title":"BJU Int"},{"key":"10.1002\/nau.22582-BIB0043|nau22582-cit-0043","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00192-006-0163-1","article-title":"Rehabilitation vs drug therapy for urge urinary incontinence: Short-term outcome","volume":"18","author":"Kafri","year":"2007","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1002\/nau.22582-BIB0044|nau22582-cit-0044","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.eururo.2011.10.043","article-title":"Prospective randomised controlled trial comparing trigone-sparing versus trigone-including intradetrusor injection of abobotulinumtoxinA for refractory idiopathic detrusor overactivity","volume":"61","author":"Manecksha","year":"2012","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22582-BIB0045|nau22582-cit-0045","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.juro.2007.05.136","article-title":"Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity","volume":"178","author":"Kuo","year":"2007","journal-title":"J Urol"},{"key":"10.1002\/nau.22582-BIB0046|nau22582-cit-0046","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/nau.21054","article-title":"Bladder base\/trigone injection is safe and as effective as bladder body injection of onabotulinumtoxinA for idiopathic detrusor overactivity refractory to antimuscarinics","volume":"30","author":"Kuo","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22582-BIB0047|nau22582-cit-0047","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/nau.20381","article-title":"Parameters of bladder function in pre-, peri-, and postmenopausal continent women without detrusor overactivity","volume":"26","author":"Pfisterer","year":"2007","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22582-BIB0048|nau22582-cit-0048","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.eururo.2012.02.036","article-title":"Anticholinergic drugs for adult neurogenic detrusor overactivity: A systematic review and meta-analysis","volume":"62","author":"Madhuvrata","year":"2012","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22582-BIB0049|nau22582-cit-0049","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1179\/2045772313Y.0000000116","article-title":"Use of botulinum toxin in individuals with neurogenic detrusor overactivity: State of the art review","volume":"36","author":"Linsenmeyer","year":"2013","journal-title":"J Spinal Cord Med"},{"key":"10.1002\/nau.22582-BIB0050|nau22582-cit-0050","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2013.10.034","article-title":"Antimuscarinics and alpha-blockers or alpha-blockers monotherapy on lower urinary tract symptoms-a meta-analysis","author":"Hao","year":"2013","journal-title":"Urology"},{"key":"10.1002\/nau.22582-BIB0051|nau22582-cit-0051","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1464-410X.2012.11559.x","article-title":"Non-steroidal anti-inflammatory drugs for lower urinary tract symptoms in benign prostatic hyperplasia: Systematic review and meta-analysis of randomized controlled trials","volume":"111","author":"Kahokehr","year":"2013","journal-title":"BJU Int"}],"container-title":["Neurourology and Urodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fnau.22582","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fnau.22582","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/nau.22582\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T20:20:35Z","timestamp":1716754835000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/nau.22582"}},"subtitle":["Pathophysiology and the Success of OAB Treatment"],"short-title":[],"issued":{"date-parts":[[2014,5,20]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,6]]}},"URL":"https:\/\/doi.org\/10.1002\/nau.22582","archive":["Portico"],"relation":{},"ISSN":["0733-2467"],"issn-type":[{"value":"0733-2467","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5,20]]}}}